Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Blauvelt

Showing results (1-10 of 323) with videos related to

Pageof 33
Sort By:
Journal of Psoriasis and Psoriatic Arthritis|September 19, 2024
Resident Memory T Cells in Psoriasis: Key to a Cure?Andrew Blauvelt
Expert Opinion on Biological Therapy|December 16, 2015
Ixekizumab: a new anti-IL-17A monoclonal antibody therapy for moderate-to severe plaque psoriasisAndrew Blauvelt
JAMA Dermatology|February 14, 2024
Reanalysis Following Removal of Participants From 1 Site in Multicenter Trial of Upadacitinib vs Dupilumab for Atopic DermatitisAndrew Blauvelt
Expert Opinion on Drug Safety|August 23, 2016
Safety of secukinumab in the treatment of psoriasisAndrew Blauvelt
JAMA Dermatology|September 19, 2019
Predicting Clinical Responses to Ustekinumab: Progress Toward a Future of Personalized MedicineAndrew Blauvelt
The Journal of Investigative Dermatology|February 26, 2017
IL-6 Differs from TNF-α: Unpredicted Clinical Effects Caused by IL-6 Blockade in PsoriasisAndrew Blauvelt
The Journal of Investigative Dermatology|April 15, 2008
T-helper 17 cells in psoriatic plaques and additional genetic links between IL-23 and psoriasisAndrew Blauvelt
The Journal of Investigative Dermatology|August 23, 2002
Essential roles for dendritic cells in the pathogenesis and potential treatment of HIV diseaseVincent Piguet, Andrew Blauvelt
Journal of the American Academy of Dermatology|January 17, 2004
Rapid publication for selected JAAD articlesAndrew Blauvelt, Jeffrey Bernhard
Clinical Reviews in Allergy & Immunology|August 16, 2018
The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis PathogenesisAndrew Blauvelt, Andrea Chiricozzi
Pageof 33

Showing results (1-10 of 323) with videos related to

Sort By:
Pageof 33
Journal of Psoriasis and Psoriatic Arthritis|September 19, 2024
Resident Memory T Cells in Psoriasis: Key to a Cure?Andrew Blauvelt
Expert Opinion on Biological Therapy|December 16, 2015
Ixekizumab: a new anti-IL-17A monoclonal antibody therapy for moderate-to severe plaque psoriasisAndrew Blauvelt
JAMA Dermatology|February 14, 2024
Reanalysis Following Removal of Participants From 1 Site in Multicenter Trial of Upadacitinib vs Dupilumab for Atopic DermatitisAndrew Blauvelt
Expert Opinion on Drug Safety|August 23, 2016
Safety of secukinumab in the treatment of psoriasisAndrew Blauvelt
JAMA Dermatology|September 19, 2019
Predicting Clinical Responses to Ustekinumab: Progress Toward a Future of Personalized MedicineAndrew Blauvelt
The Journal of Investigative Dermatology|February 26, 2017
IL-6 Differs from TNF-α: Unpredicted Clinical Effects Caused by IL-6 Blockade in PsoriasisAndrew Blauvelt
The Journal of Investigative Dermatology|April 15, 2008
T-helper 17 cells in psoriatic plaques and additional genetic links between IL-23 and psoriasisAndrew Blauvelt
The Journal of Investigative Dermatology|August 23, 2002
Essential roles for dendritic cells in the pathogenesis and potential treatment of HIV diseaseVincent Piguet, Andrew Blauvelt
Journal of the American Academy of Dermatology|January 17, 2004
Rapid publication for selected JAAD articlesAndrew Blauvelt, Jeffrey Bernhard
Clinical Reviews in Allergy & Immunology|August 16, 2018
The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis PathogenesisAndrew Blauvelt, Andrea Chiricozzi
Pageof 33